SCHEMBL9003705

SCHEMBL9003705

COC(=O)[C@@H](N)CC(=O)CP(=O)(O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36
OTC P00480 1/20 0.36
ANPEP P15144 1/20 0.34
ENO1 P06733 1/20 0.33
LAP3 P28838 1/20 0.33
CA2 P00918 1/20 0.33
CA4 P22748 1/20 0.33
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20640411 1.00 CYP2D6 (0.39) CYP2D6CYP2C9CYP2C19GRIN2DGRIN3B
SCHEMBL9003696 1.00 CYP2D6 (0.39) CYP2D6CYP2C9CYP2C19GRIN2DGRIN3B
SCHEMBL9003713 0.84 CYP2D6 (0.53) CYP2D6CYP2C9CYP2C19GRIN2DGRIN3B
SCHEMBL20640447 0.84 CYP2D6 (0.53) CYP2D6CYP2C9CYP2C19GRIN2DGRIN3B
SCHEMBL9003702 0.84 CYP2D6 (0.53) CYP2D6CYP2C9CYP2C19GRIN2DGRIN3B
SCHEMBL21557288 0.76 TDP1 (0.38) CA2KMT2ATDP1
SCHEMBL1431004 0.76 OTC (0.47) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8467545 0.76 OTC (0.47) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL31301851 0.76 ANPEP (0.39) CYP2D6CYP2C9CYP2C19ANPEPLAP3
SCHEMBL195547 0.76 OTC (0.47) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5538958-A NMDA antagonists MERRELL PHARMACEUTICALS INC. (US) 1996-07-23 US disclosed
US-5500419-A NMDA antagonists MERRELL DOW PHARMACEUTICALS INC. (US) 1996-03-19 US disclosed
EP-0418863-B1 NMDA antagonists MERRELL DOW PHARMA (US) 1995-01-04 EP disclosed
US-5326756-A R-4-oxo-5 phosphononorvaline used as NMDA antagonists MERRELL DOW PHARMACEUTICALS INC. (US) 1994-07-05 US disclosed
US-5095009-A NMDA antagonists MERRELL DOW PHARMACEUTICALS INC. (US) 1992-03-10 US disclosed
EP-0418863-A2 NMDA antagonists MERRELL DOW PHARMACEUTICALS INC. (US) 1991-03-27 EP disclosed